Terns Pharmaceuticals Inc is a biopharmaceutical company focused on developing treatments for serious medical conditions such as cancer, non-alcoholic steatohepatitis (NASH), and obesity. With a pipeline that includes TERN-701 for chronic myeloid leukemia, TERN-501 for NASH, and TERN-601 for NASH and obesity, the company is dedicated to advancing healthcare through innovation. Founded in 2016 and based in Foster City, California, Terns Pharmaceuticals is at the forefront of creating novel therapies for complex diseases.
Merck (NYSE:MRK | MRK Price Prediction) reports third-quarter results on Thursday, Oct. 29. KEYTRUDA still anchors the business, but I’ll be watching whether newer launches are growing fast enough to cushion the…
Pre-Market Stock Futures: Futures are trading higher this morning after reports are circulating that President Trump wants to end the war soon. This comes after Monday’s session, which saw three of the…
Pre-Market Stock Futures: Futures are trading lower as we prepare to end another up-and-down week, and, as we mentioned before, it all depends on the status of the war with Iran and…
Penny stocks captivate investors with their low prices. The allure of controlling large numbers of shares for relatively very little money, and potentially generating explosive gains if their stocks move just a…
Terns Pharmaceuticals Inc is a biopharmaceutical company focused on developing treatments for serious medical conditions such as cancer, non-alcoholic steatohepatitis (NASH), and obesity.
